Findings of fluorine-18-FDG PET in extranodal origin lymphoma —In three cases of diffuse large B cell type lymphoma—

Takashi Nihashi; Kazumasa Hayasaka; Rikio Kato; Toshihide Itou; Kengo Ito; Toshiharu Okae; Takeo Ishigaki

首页> 外文期刊>Annals of Nuclear Medicine >Findings of fluorine-18-FDG PET in extranodal origin lymphoma —In three cases of diffuse large B cell type lymphoma—

【24h】

Findings of fluorine-18-FDG PET in extranodal origin lymphoma —In three cases of diffuse large B cell type lymphoma—

机译：在结外源性淋巴瘤中发现氟-18-FDG PET —在三例弥漫性大B细胞型淋巴瘤中—

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

F-l 8 fluorodeoxyglucose (FDG) positron emission tomography (PET) is an excellent modality for non-invasive functional imaging of malignant lymphoma and is highly sensitive and specific for the detection of lymphoma lesions. Here, we report the findings of FDG-PET for three cases of diffuse large B cell type lymphoma (DLBCL) with extranodal tumors in the breast, stomach, and liver plus spleen, respectively. The whole body FDG-PET findings showed no evidence of lymph node (LN) involvement or distant metastasis. Strong FDG accumulations were observed in the only extranodal sites by whole body FDG-PET. Therefore, we could confirm that these cases were extranodal primary origins. Whole body PET is useful to determine the primary sites, that is, extranodal origin DLBCL with its clear images.

机译：F-18氟脱氧葡萄糖（FDG）正电子发射断层显像（PET）是恶性淋巴瘤非侵入性功能成像的极佳模式，并且高度敏感且对淋巴瘤病变的检测具有特异性。在这里，我们报告了FDG-PET在三例弥漫性大B细胞型淋巴瘤（DLBCL）中分别在乳腺，胃和肝以及脾脏中有结外肿瘤的发现。全身FDG-PET的发现未显示淋巴结（LN）受累或远处转移的迹象。通过全身FDG-PET，仅在结外部位观察到强烈的FDG积累。因此，我们可以确认这些病例是结外主要起源。全身PET可用于确定主要部位，即具有清晰图像的结外起源DLBCL。

著录项

来源
《Annals of Nuclear Medicine》 |2006年第10期|689-693|共5页
作者
Takashi Nihashi; Kazumasa Hayasaka; Rikio Kato; Toshihide Itou; Kengo Ito; Toshiharu Okae; Takeo Ishigaki;
展开▼
作者单位

Department of Radiology National Center for Geriatrics and Gerontology 36-3 Gengo 474-8522 Morioka-cho Ohbu JAPAN;

Department of Radiology National Center for Geriatrics and Gerontology 36-3 Gengo 474-8522 Morioka-cho Ohbu JAPAN;

Department of Radiology National Center for Geriatrics and Gerontology 36-3 Gengo 474-8522 Morioka-cho Ohbu JAPAN;

Department of Hematology National Center for Geriatrics and Gerontology JAPAN;

Department of Radiology National Center for Geriatrics and Gerontology 36-3 Gengo 474-8522 Morioka-cho Ohbu JAPAN;

Department of Brain Science and Molecular Imaging National Institute for Longevity Sciences JAPAN;

Department of Radiology Anjo General Hospital JAPAN;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
extranodal lymphoma; FDG-PET; DLBCL;

机译：结外淋巴瘤;FDG-PET;DLBCL;

相似文献

外文文献
中文文献
专利

1. Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: A study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept [J] . AignerF., KorolD., SchmittA.M., Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2012,第5期

机译：皮肤滤泡中心淋巴瘤类型的结外弥漫性大B细胞淋巴瘤类型：对24例非皮肤原发性有限期结外性弥漫性大B细胞淋巴瘤患者的研究
2. A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma [J] . Hidetsugu Kawai, Hiromichi Matsushita, Shohei Kawakami, Journal of clinical and experimental hematopathology : . 2019,第1期

机译：淋巴结性NK / T细胞淋巴瘤，鼻型和弥漫性大B细胞淋巴瘤的复合淋巴瘤1例
3. Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin? [J] . Laszlo D, Pruneri G, Andreola G, International journal of surgical pathology . 2011,第4期

机译：弥漫性大B细胞淋巴瘤中的组织芯片：它们真的能够确定淋巴结和淋巴结外淋巴瘤的不同预后组吗？
4. Marker gene identification for gene expression analysis — Review and new findings for Diffused Large B Cell Lymphoma (DLBCL) [C] . Xi-Guang Wei, Ho-Chun Wu, Shing-Chow Chan International Conference on Digital Signal Processing . 2016

机译：用于基因表达分析的标记基因鉴定—扩散大B细胞淋巴瘤（DLBCL）的综述和新发现
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma Nasal-type and Diffuse Large B-cell Lymphoma [O] . Hidetsugu Kawai, Hiromichi Matsushita, Shohei Kawakami, 2019

机译：淋巴结性NK / T细胞淋巴瘤鼻型和弥漫性大B细胞淋巴瘤的复合淋巴瘤1例
7. Exclusive Detection of the t(11;18)(q21;q21) in Extranodal Marginal Zone B Cell Lymphomas (MZBL) of MALT Type in Contrast to other MZBL and Extranodal Large B Cell Lymphomas [O] . Rosenwald, Andreas, Ott, German, Stilgenbauer, Stephan, 1999

机译：与其他MZBL和结外大B细胞淋巴瘤形成对比的MALT型结外边缘B区淋巴瘤（MZBL）的t（11; 18）（q21; q21）独家检测

Findings of fluorine-18-FDG PET in extranodal origin lymphoma —In three cases of diffuse large B cell type lymphoma—

摘要

著录项

相似文献

相关主题

期刊订阅